Search

everythinglearnresearchcommunity

for

Search:↓

Certain vitamins in wrong amounts, alcohol abuse, metals, and other toxins can cause serious brain and nerve damage.

Porphyria cutanea tarda causes skin issues due to an enzyme deficiency.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Hypertrichosis causes excessive hair growth and needs psychological support due to its impact on self-esteem.

People with chronic Hepatitis C often have skin problems like itching and contact dermatitis, especially older individuals and women.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

The document discusses various challenging skin conditions and their treatments.

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

Postinflammatory hyperpigmentation causes dark skin patches and needs personalized treatment.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Carbamazepine may cause reversible nail detachment.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Panitumumab can cause excessive ear hair growth.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

More frequent and severe skin problems are linked to higher daily alcohol consumption.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

A woman's skin symptoms led to a diagnosis of systemic AL amyloidosis, but she died from sepsis shortly after.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

Targeted cancer therapies often cause serious skin problems that need careful management.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.